Dilated Cardiomyopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-06-19
Clinical Trial Update: Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating intravenous allopurinol to improve heart function in dilated cardiomyopathy has been withdrawn.